Feedback

Emerging role of SENP1 in tumorigenesis and cancer therapy

Affiliation
Department of Experimental Research ,Guangxi Medical University Cancer Hospital ,Nanning ,China
Lin, Min;
Affiliation
Department of Experimental Research ,Guangxi Medical University Cancer Hospital ,Nanning ,China
Zhang, Man;
Affiliation
Department of Experimental Research ,Guangxi Medical University Cancer Hospital ,Nanning ,China
Yi, Bei;
Affiliation
Department of Experimental Research ,Guangxi Medical University Cancer Hospital ,Nanning ,China
Chen, Jinchi;
Affiliation
Department of Experimental Research ,Guangxi Medical University Cancer Hospital ,Nanning ,China
Wen, Siqi;
Affiliation
Department of Gastrointestinal Surgery ,Guangxi Clinical Research Center for Colorectal Cancer ,Guangxi Medical University Cancer Hospital ,Nanning ,China
Chen, Ruiqi;
Affiliation
Department of Gastrointestinal Surgery ,Guangxi Clinical Research Center for Colorectal Cancer ,Guangxi Medical University Cancer Hospital ,Nanning ,China
Chen, Tianyu;
Affiliation
Department of Experimental Research ,Guangxi Medical University Cancer Hospital ,Nanning ,China
Li, Zhao

Acting as a cysteine protease, small ubiquitin-like modifier (SUMO)/sentrin-specific protease1 (SENP1) involved in multiple physiological and pathological processes through processing the precursor SUMO protein into mature form and deSUMOylating target protein. It has been reported that SENP1 is highly expressed and plays a carcinogenic role in various cancers. In this paper, we mainly explore the function and mechanism of SENP1 in tumor cell proliferation, apoptosis, invasion, metastasis, stemness, angiogenesis, metabolism and drug resistance. Furthermore, the research progress of SENP1 inhibitors for cancer treatment is introduced. This study aims to provide theoretical references for cancer therapy by targeting SENP1.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2024 Lin, Zhang, Yi, Chen, Wen, Chen, Chen and Li.

Use and reproduction: